KATHLEEN FLOOD: Open Payments
NPI 1053021816 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 29 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $823 · 2025 $688
Food & beverage: $688
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $126 |
| Verona Pharma, Inc. | 5 | $122 |
| ABBVIE INC. | 3 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Phathom Pharmaceuticals, Inc. | 3 | $60 |
| Lilly USA, LLC | 2 | $44 |
| Novo Nordisk Inc | 2 | $43 |
| Viatris Specialty LLC | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
Products named: Ohtuvayre, FARXIGA, REXULTI, VOQUEZNA, Ozempic, VRAYLAR, AVYCAZ, YUPELRI.
Industry payments across MA — which companies pay providers there.
